Determination of Sensitivity of Fresh Leukemia Cells to Immunotoxins

Cancer Research

Volumn 46, Issue 5, 1986, Pages 2289-2294

  Laurent, G ^a   Kuhlein, E ^a   Jansen, F K ^a,b   Casellas, P ^a   Carayon, P ^a   Poncelet, P ^a   Correll, S ^a   Canat, X ^a   Rigal, F ^b  

^a SANOFI   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; MONOCLONAL ANTIBODY; RADIOISOTOPE; RICIN A;

BLOOD AND HEMOPOIETIC SYSTEM; CANCER IMMUNOTHERAPY; CELL LINE; DOSE RESPONSE; DRUG RESPONSE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; THERAPY; TOPICAL DRUG ADMINISTRATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA; NEOPLASM PROTEINS; RICIN;

EID: 0022617674     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Casellas, P., Canat, X., Fauser, A. A., Gros, O., Laurent, G., Poucelet, P., and Jansen, F.K. Optimal elimination of leukemic T–cells from human bone marrow with I 101 ricin A cimili immunotoxins. Blood, 65: 289-297, 1985.
2. Muirhead, M., Martin, P. J., Torok-Storb, B., Uhr, J. W., and Vitella, E. S. Use of an antibody-ricin A chain conjugate lo delele neoplaslic B-ceIIs Ircun hnman bone marrow. Blood, 62:327-332, 1983.
3. Myers, C. C., Thorpe, P. E., Ross, W. C. J., Cumber, A. J., Kalz, F. E., Tax, W., and Greaves, M. F. An immunotoxin with therapeutic potential in Tcell acute leukemia: WTl-ricin A. Blood, 63:1178-1185,1984.
4. Stong, R. C., Youle, R. J., and Vallera, D. A. Elimination of clonogenk Tleukemic cells from human bone marrow using anti-AS, 65,000 prolein immunotoxins. Cancer Res., 44: 3000-3006, 1984.
5. Uckun, F. M., Ramakrishnan, S., and Houston, L. L. Increased efficiency in selective elimination of leukemia cells by a combination of a slable derivative of cyclophosphamide and a human H cell specific inuminoleixin conlaining pokeweed anti–viral prolein. Cancer Res., 45:69-75, 1985.
6. Wiels, J., Junqua, S., Dujardin, P., Le Pecq, J.B., and Tursz, T. Properties of immunotoxins against a glycolipid antigen associated with Burkilt's lym Phoma. Cancer Res., 44:129-133, 1984.
7. MacCulloch, E. A., Curtis, J. E., Messner, H. A., Senn, J. S., and Germanson, T. P. The contribution of blasl cell properlies lo oulcome variation in acute myclohlasiaicleukemia (AML). Blood, 59:601-608, 1982.
8. Poncelci, P. and Carayon, P. Cylofluoromelric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J. Immunol. Methods, 85:65-74, 1985.
9. Gros, O., Gros, P., Jansen, F. K. and Vidal, H. Biochemical aspects of immunotoxin preparation. J. Immunol. Methods, 81:283-297, 1985.
10. Casellas, P., Brown, J.P., Gros, O., Gros, P., Hellstrom, L., Jansen, F., Poncelet, P., Roncucci, R., Vidal, H., and Hellslrom, K.E. Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma associated antigen p97. Int. J. Cancer, 30:437-443, 1982.
11. I. chacu., Ver heulen, A.M., Ravoet, A.M., Bazin, H., Sutherland. D.R., Tidman, N., and Greaves, M.F. Ral AL2, AL3, AL4, and ALS monoclonal antibodies bind to ihe common acule lymphoblaslic leukaemia antigen (Calla gplOO). Int. J. Cancer, 32:273-279, 1983.
12. Boucheix, C., Ferrol, J. Y., Mirshahi, M., Fournier, N., Billard, M., Giannoni, F., Bernadou, A., and Rosenfeld, C. Monoclonal antibodies againsl acule lymphoblaslic leukemia differentiation antigens. In: A. Bernard, L. Boumsell, J. Dausset, C. Milslein, and S. F. Schlossman (eds.). Leucocyte Typing, pp. 671-672. Berlin: Springer-Verlag, 1984.
13. Casellas, P., Bourne, B. J. P., Gros, P., and Jansen, F. K. Kinetics of cytotoxicily induced by immunotoxins: enhancement by lysosomotropic amines and carboxylic ionophores. J. Biol. Chem., 259:9359-9364, 1984.
14. Poncclct, P., Blythman, H. E., Carriere, D., Cascuas, P., Dussossoy, D., Gros, O., Gros, P., Jansen, F. K., Laurent J. C., Liante, M. C., Vidal, H., and Voisin, G. A. Present potential of immunotoxins. Behring Inst. Milt., 74:94-100, 1984.
15. Maraninchi D., Novakovilch, G., Laurent. G., Mascret, B., Tulliana, N., Derocq, J. M., Casellas, P., Gastaut, J. A., Perrimond, H., and Carcassone, Y. Bone marrow iransplanlalion after in vitro purging wilh TlOl-ricin Achain immunoloxins: a phase I clinical sludy. In: K. A. Dicke, G. Spilzer, and A. R. Zander (eds.), Aulologous Bone Marrow Transplantation. Proceedings of ihe I irsi International Symposium, pp. 425-427. Houston: The University of Texas M. D. Anderson Hospital and Tumor Institute, 1985.
16. Filipovich, A. H., Vallera, D. A., Youle, R. J., Stong, R. C., Neville, D. M., and Kersey, J. H. Marrow purging with immunoloxins in allogeneic and aulologous bone marrow Iransplanlalion: pilol clinical studies. In: K. A. Dicke, G. Spilzer, and A. R. Zander (eds.), Aulologous Bone Marrow Transplantation. Proceedings of the First International Symposium, pp. 403-407. Houston: The University of Texas M. D. Anderson Hospital and Tumor Inslilute, 1985.
17. Seon, B. K., Specific killing of Human T-leukemia sell by immunotoxins prepared with ricin A–chain and monoclomal anti-human T–cell leukemia antibodies. Cancer Res., 44: 259-264, 1984.
18. Haynes, B. F., Melzgar, R. S., Minna, J. D., and Bunn, P. A. Phenolyping characterization of cutaneous T cell lymphoma: use of monoclonal antibodies to compare with olher malignant T–cells. N. Engl. J. Med., 304:1319-1328,1981.
19. Royslon, I., Majda, J. A., Baird, S. M., Meserve, B. L., and Griffiths, J. C. Human I cell antigens defined by monoclonal antibodies: Ihe 65,000 dalton antigen of T–cells(T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J. Immunol., 125:725-731, 1980